rs183951324
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015459.5(ATL3):c.1522G>A(p.Ala508Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,611,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A508P) has been classified as Uncertain significance.
Frequency
Consequence
NM_015459.5 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory, type 1FInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015459.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATL3 | NM_015459.5 | MANE Select | c.1522G>A | p.Ala508Thr | missense | Exon 12 of 13 | NP_056274.3 | ||
| ATL3 | NM_001440716.1 | c.1471G>A | p.Ala491Thr | missense | Exon 11 of 12 | NP_001427645.1 | |||
| ATL3 | NM_001290048.2 | c.1468G>A | p.Ala490Thr | missense | Exon 12 of 13 | NP_001276977.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATL3 | ENST00000398868.8 | TSL:1 MANE Select | c.1522G>A | p.Ala508Thr | missense | Exon 12 of 13 | ENSP00000381844.3 | ||
| ATL3 | ENST00000538786.1 | TSL:2 | c.1468G>A | p.Ala490Thr | missense | Exon 12 of 13 | ENSP00000437593.1 | ||
| ENSG00000256789 | ENST00000540307.2 | TSL:3 | n.121-6434C>T | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152076Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000283 AC: 7AN: 246936 AF XY: 0.00000747 show subpopulations
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1459174Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 725760 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000158 AC: 24AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74426 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory, type 1F Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 508 of the ATL3 protein (p.Ala508Thr). This variant is present in population databases (rs183951324, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with ATL3-related conditions. ClinVar contains an entry for this variant (Variation ID: 541688). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.1522G>A (p.A508T) alteration is located in exon 12 (coding exon 12) of the ATL3 gene. This alteration results from a G to A substitution at nucleotide position 1522, causing the alanine (A) at amino acid position 508 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at